Shilpa Medicare has raised around Rs 172.42 crore by allotting 30.25 lakh shares to Mauritius-based TA FII Investors. The company's board of directors has allotted this equity share of Re 1 each at a premium of Rs 569 per share in the name of TA FII Investors. This is pursuant to the resolution passed by the company's shareholders at the EGM held on December 26, 2016.
Shilpa Medicare produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.
